Evidence map›Paper›PMID 36669113›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming.

Serena F Generoso, Maria Victoria Neguembor, Elliot A Hershberg, Ruslan I Sadreyev, Kazuki Kurimoto, Yukihiro Yabuta, Raffaele Ricci, Pauline Audergon, Moritz Bauer, Mitinori Saitou and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Function and Evolution of the Loop Extrusion Machinery in Animals.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Serena F GenerosoCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
Maria Victoria NeguemborCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.ORCID 0000-0002-1583-1304
Elliot A HershbergDepartment of Genome Sciences, University of Washington, Seattle, WA 98195.
Ruslan I SadreyevDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Kazuki KurimotoInstitute for the Advanced Study of Human Biology, Kyoto University, Kyoto 606-8501, Japan.
Yukihiro YabutaInstitute for the Advanced Study of Human Biology, Kyoto University, Kyoto 606-8501, Japan.
Raffaele RicciCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
Pauline AudergonCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
Moritz BauerOncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht 3584, The Netherlands.
Mitinori SaitouInstitute for the Advanced Study of Human Biology, Kyoto University, Kyoto 606-8501, Japan.
Konrad HochedlingerDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Brian J BeliveauDepartment of Genome Sciences, University of Washington, Seattle, WA 98195.ORCID 0000-0003-1314-3118
Maria Pia CosmaCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
Jeannie T LeeDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Bernhard PayerCentre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona 08003, Spain.ORCID 0000-0002-4694-2082
Centre for Genomic Regulation · ESKyoto University · JPMassachusetts General Hospital · USUniversity of Washington · USHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESRoyal Netherlands Academy of Arts and Sciences · NLUniversitat Pompeu Fabra · ES

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Regulation of X-Inactivation by Non-Coding RNA LociR01GM058839 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, JEANNIE T · 1999 to 2025
$6.7M
Investigating a candidate therapeutic for Rett SyndromeR01MH118351 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI JEANNIE T LEE · 2019 to 2026
$6.2M
Probing the dynamics of chromosome organization in single cellsR35GM137916 · NIGMS · UNIVERSITY OF WASHINGTON · PI Brian Joseph Beliveau · 2020 to 2026
$2.9M
NIDDK NIH HHS P30 DK040561NIGMS NIH HHS R01 GM058839NIGMS NIH HHS R35 GM137916NIMH NIH HHS R01 MH118351
6 · The paper itself

Abstract

Reactivation of the inactive X chromosome is a hallmark epigenetic event during reprogramming of mouse female somatic cells to induced pluripotent stem cells (iPSCs). This involves global structural remodeling from a condensed, heterochromatic into an open, euchromatic state, thereby changing a transcriptionally inactive into an active chromosome. Despite recent advances, very little is currently known about the molecular players mediating this process and how this relates to iPSC-reprogramming in general. To gain more insight, here we perform a RNAi-based knockdown screen during iPSC-reprogramming of mouse fibroblasts. We discover factors important for X chromosome reactivation (XCR) and iPSC-reprogramming. Among those, we identify the cohesin complex member SMC1a as a key molecule with a specific function in XCR, as its knockdown greatly affects XCR without interfering with iPSC-reprogramming. Using super-resolution microscopy, we find SMC1a to be preferentially enriched on the active compared with the inactive X chromosome and that SMC1a is critical for the decompacted state of the active X. Specifically, depletion of SMC1a leads to contraction of the active X both in differentiated and in pluripotent cells, where it normally is in its most open state. In summary, we reveal cohesin as a key factor for remodeling of the X chromosome from an inactive to an active structure and that this is a critical step for XCR during iPSC-reprogramming.

Indexed as

Induced Pluripotent Stem CellsAnimalsCellular ReprogrammingChromosome StructuresCohesinsFemaleMiceX ChromosomeX Chromosome InactivationCohesinscellular reprogrammingcohesinX chromosomeX-inactivationX-reactivation

Identifiers

PMID36669113
PMCPMC9942853
OpenAlexW4317566710

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.